Table 1 Patient Demographics and Perioperative Characteristics
Characteristic | Group C (n = 17) | Group I (n = 16) | Group S (n = 18) | P values |
|---|---|---|---|---|
Age (years) | 54.41 ± 6.62 | 55.19 ± 5.94 | 55.94 ± 5.14 | NS |
Gender (M/F) | 4/13 | 4/12 | 6/12 | NS |
BMI (kg/m2) | 22.48 ± 1.30 | 22.54 ± 0.80 | 22.51 ± 0.90 | NS |
ASA (I/II) | 7/10 | 8/8 | 8/10 | NS |
Type of aneurysm (number%) | Â | Â | Â | NS |
 Middle cerebral artery | 11 (64.6%) | 12 (75%) | 13 (72.2%) |  |
 Anterior communicating artery | 2 (11.8%) | 0 | 1 (5.6%) |  |
 Posterior communicating artery | 2 (11.8%) | 2 (12.5%) | 3 (16.6%) |  |
 Anterior cerebral artery | 2 (11.8%) | 2 (12.5%) | 1 (5.6%) |  |
Duration of operation (min) | 169.41 ± 44.75 | 161.88 ± 36.69 | 155.56 ± 40.94 | NS |
Duration of anesthesia (min) | 252.94 ± 42.65 | 248.44 ± 36.96 | 240.28 ± 41.53 | NS |
Total dose of propofol (mg) | 1854.65 ± 375.03 | 1820.88 ± 233.17 | 1716.33 ± 206.67 | NS |
Total dose of remifentanil (mg) | 4.59 ± 0.64 | 3.67 ± 0.38 | 1.40 ± 0.38 | 0.000* |
Total loss of blood (ml) | 370.59 ± 161.11 | 393.75 ± 166.21 | 305.56 ± 93.76 | NS |
Urine volume (ml) | 1135.29 ± 337.16 | 1218.75 ± 335.10 | 1055.56 ± 261.72 | NS |
Infusion volume (ml) | ||||
 Crystalloids (ml) | 1361.76 ± 644.58 | 1468.75 ± 618.30 | 1147.22 ± 269.24 | NS |
 Colloids (ml) | 1161.76 ± 264.30 | 1109.38 ± 240.98 | 1111.11 ± 213.90 | NS |
Number of use of nicardipine(%) | 8 (47.1%) | 3 (18.8%) | 1 (5.6%) | 0.017# |
Number of use of esmolol(%) | 0 | 0 | 0 | NA |